Asthma drug shows promise in slowing diabetic kidney damage
NCT ID NCT07022418
Summary
This study is testing if adding a drug called formoterol to standard care can help treat diabetic kidney disease. Formoterol is a medication commonly used for asthma, and early research suggests it may help protect kidney cells. The trial will enroll 120 adults with type 2 diabetes and kidney damage to see if the drug is safe, well-tolerated, and shows signs of slowing the disease over 36 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC KIDNEY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medical University of South Carolina
RECRUITINGCharleston, South Carolina, 29425, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.